Product Information
DABIGATRAN ETEXILATE 75 MG CAP is a generic product labeled by Major Pharmaceuticals, priced at $0.8983 per EA under NDC 00904725368. Its NADAC has been published 43 times since Sep 3, 2025.
The Low Outlier badge above means this manufacturer's average price in the Dabigatran Etexilate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
75 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904725368
Classification
Generic
Dosage Form
CAPSULE, COATED PELLETS
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DABIGATRAN ETEXILATE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA208040On Market Since
6/23/2025
Pharmacological Classes
Price Statistics
The NADAC for DABIGATRAN ETEXILATE 75 MG CAP has been published 43 times since Sep 3, 2025, and over the history we have for it it has declined 23.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8983 per EA |
|---|---|
| All-time high | $1.1670 (Sep 10, 2025) |
| All-time low | $0.8478 (Apr 22, 2026) |
| 52-week high | $1.1670 |
| 52-week low | $0.8478 |
| Median price | $1.0547 |
| Average price | $1.0201 |
| Largest weekly change | -10.0% (Apr 22, 2026) |
| Weeks tracked | 43 |
| Tracking since | Sep 3, 2025 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DABIGATRAN ETEXILATE 75 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DABIGATRAN ETEXILATE 75 MG CAP, manufactured by Major Pharmaceuticals, is $0.8983 per EA (NDC 00904725368), effective Jun 24, 2026.
How has the price of DABIGATRAN ETEXILATE 75 MG CAP changed over time?
Over the history we have for it, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has declined 23.0%. It has been tracked across 43 weekly CMS publications since Sep 3, 2025.
What are the highest and lowest recorded NADAC prices for DABIGATRAN ETEXILATE 75 MG CAP?
Since Sep 3, 2025, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has ranged from a low of $0.8478 (Apr 22, 2026) to a high of $1.1670 (Sep 10, 2025), with a median of $1.0547 per EA.
Are there cheaper alternatives to DABIGATRAN ETEXILATE 75 MG CAP?
5 NADAC-published products share the same active ingredient, strength, and dosage form as DABIGATRAN ETEXILATE 75 MG CAP, but none are currently priced below it.
Who manufactures DABIGATRAN ETEXILATE 75 MG CAP?
DABIGATRAN ETEXILATE 75 MG CAP (NDC 00904725368) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification